European registry on helicobacter pylori management: Effectiveness of first and second-line treatment in Spain

The management of Helicobacter pylori infection has to rely on previous local effectiveness due to the geographical variability of antibiotic resistance. The aim of this study was to evaluate the effectiveness of first and second-line H. pylori treatment in Spain, where the empirical prescription is recommended. A multicentre prospective non-interventional registry of the clinical practice of European gastroenterologists concerning H. pylori infection (Hp-EuReg) was developed, including patients from 2013 until June 2019. Effectiveness was evaluated descriptively and through a multivariate analysis concerning age, gender, presence of ulcer, proton-pump in-hibitor (PPI) dose, therapy duration and compliance. Overall, 53 Spanish hospitals were included, and 10, 267 patients received a first-line therapy. The best results were obtained with the 10-day bismuth single-capsule therapy (95% cure rate by intention-to-treat) and with both the 14-day bismuth-clarithromycin quadruple (PPI-bismuth-clarithromycin-amoxicillin, 91%) and the 14-day non-bismuth quadruple concomitant (PPI-clarithromycin-amoxicillin-metronidazole, 92%) therapies. Second-line therapies were prescribed to 2448 patients, with most-effective therapies being the triple quinolone (PPI-amoxicillin-levofloxacin/moxifloxacin) and the bismuth-levofloxacin quadruple schemes (PPI-bismuth-levofloxacin-amoxicillin) prescribed for 14 days (92%, 89% and 90% effective-ness, respectively), and the bismuth single-capsule (10 days, 88.5%). Compliance, longer duration and higher acid inhibition were associated with higher effectiveness. “Optimized” H. pylori therapies achieve over 90% success in Spain

A review of the fossil record of turtles of the clade Pan-Carettochelys

Turtles of the total clade Pan-Carettochelys have a relatively poor fossil record that extends from the Early Cretaceous. The clade is only found in Asia during the Cretaceous, but spreads to Europe and North America during the Eocene. Neogene finds are restricted to Europe, Africa and Australia, whereas the only surviving species, Carettochelys insculpta, lives in New Guinea and the Northern Territories of Australia. The ecology of fossil pan-carettochelyids appears similar to that of the extant C. insculpta, although more primitive representatives were likely less adapted to brackish water. Current phylogenies only recognize three internested clades: Pan- Carettochelys, Carettochelyidae and Carettochelyinae. A taxonomic review of the group concludes that of 25 named taxa, 13 are nomina valida, 7 are nomina invalida, 3 are nomina dubia, and 2 are nomina nuda

EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI) : Study protocol for a multicentre, observational trial

More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University Münster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials. Trial registration number NCT04165369

Lexicon ecclesiasticum latino hispanicum, ex Sacris Bibliis, Conciliis Pontificum, ac Theologorum Decretis, diuorum vitis, varijs dictionarijs, alisq[ue] probatissimis scriptoribus concinnatum... opus novum..

Sign.: [parágrafo]\p4\s, A-V\p8\s, []\p1\sTexto a dúas col. con reclamosPort. a dúas tintas con esc. xi

Enchiridion o Manual de Doctrina Christiana (que tambien puede seruir de Confessionario) : diuidido en cinco partes... / hecho y côpilado de muchos libros de sana doctrina por el R. P. fray Diego Ximenez...

Lugar, impresor y librero constan en colofónEnc. Perg.Sign.: +8, A-T8, [ ]

Lexicon ecclesiasticum latino-hispanicum, ex sacris bibliis, concilius, pontificum decretis, ac theologorum placitis divorum vitis : variis dictonariis aliisque probatissimis scriptoribus concinnatum ...

Sign.: [ ]\p4\s, A-Z\p4\s, 2A-2Z\p4\s, 3A-3H\p4\s, 3I\p3\s, [ ]\p1\s, A-C\p4\sAntepTexto a dos co

Arte del computo

Nunc denuo ab eodem authore... auctum, et locupletatum multis additionibus adiectis...Al fin: "Arte del computo, nuevamente compuesta por... Hieronymo de Valencia..."Enc. Perg.Sign.: [4], A-Z8, 2A8, 2B6, +

Lexicon Ecclesiasticum latino hispanicum ex sacris Bibliis, Conciliis, Pontificum ac Theologorum Decretis, diuorum vitis, variis dictionariis, aliisque probatiss. scriptoribus concinnatum... / autore F. Didaco Ximenez Arias...

El autor del cómputo consta el h. 291 v.Port. con grab. xil.Enc. Perg.Sign.: a4, A-Z8, Aa-Oo